Moustafa E El-Araby

Title: Moustafa E El-Araby: Innovator in Cancer Treatment

Introduction

Moustafa E El-Araby is a notable inventor based in Richmond, VA (US). He has made significant contributions to the field of cancer research, particularly in the treatment of acute myeloid leukemia (AML). His innovative work has led to the development of a patent that holds promise for therapeutic applications.

Latest Patents

Moustafa E El-Araby holds a patent for "2-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of acute myeloid leukemia." This patent identifies three compounds with a common molecular template of 2-(5-(N-acylamino)pyridin-2-yl)-N-benzylacetamide, which are recognized as potential anticancer therapeutic agents. Compound I, in particular, was designed to target AML cells, inhibit their growth, and induce cell death. It has demonstrated a dose-dependent effect on various AML cell lines, including HL-60, Mv4-11, KG-1a, and K562.

Career Highlights

Throughout his career, Moustafa E El-Araby has worked with prestigious institutions such as the University of Jeddah and King Abdulaziz University. His research has focused on developing effective treatments for cancer, showcasing his commitment to advancing medical science.

Collaborations

Moustafa has collaborated with talented individuals in his field, including Roaa M Alreemi and Hind A Alkhatabi. These partnerships have contributed to the success of his research and the development of innovative solutions in cancer treatment.

Conclusion

Moustafa E El-Araby is a dedicated inventor whose work in cancer research has the potential to make a significant impact on the treatment of acute myeloid leukemia. His innovative compounds and collaborations highlight his commitment to advancing medical science and improving patient outcomes.